Salix Pharmaceuticals
Michael Mohan has a diverse work experience in the pharmaceutical industry. Michael started their career at Sanofi as a Sales Professional from July 2008 to January 2010. Michael then joined Warner Chilcott, where they worked as a Pharmaceutical Sales Representative from May 2010 to September 2011, followed by a promotion to Senior District Manager from September 2011 to April 2013, and finally as an Associate Director of Sales from April 2013 to March 2014. In 2014, they joined Baxter International Inc. as a Regional Business Director from March 2014 to September 2014. Michael then moved to Salix Pharmaceuticals, where they held various roles, including Regional Business Manager from September 2014 to September 2016, East Regional Sales Director from October 2016 to present, and currently works as a Senior Sales Director since January 2022.
Michael Mohan attended the Boston College Carroll School of Management, where they pursued a Bachelor of Science (B.S.) degree in Finance. No start or end years were provided for their education at this institution.
This person is not in any offices
Salix Pharmaceuticals
3 followers
Salix Pharmaceuticals is one of the largest specialty pharmaceutical companies in the world committed to the prevention and treatment of gastrointestinal (GI) diseases. We offer effective solutions and strive to be the first to discover what patients need next. We gain a deeper understanding of the GI conditions our products treat by connecting with the patients who use them and the healthcare professionals (HCPs) who prescribe them. Our therapeutic areas of expertise include management of conditions such as hepatic encephalopathy, irritable bowel syndrome with diarrhea, opioid-induced constipation, and ulcerative colitis. We employ dedicated and innovated team members who are driven to solve problems. We improve upon existing treatments, uncover new breakthroughs, and deliver comprehensive practice support to help HCPs provide best-in-class care. The landscape of healthcare will continue to change and new patients will continue to present with new needs. That’s why there is no finish line for our innovation and no limits to our potential. See our Community Guidelines: https://www.bauschhealth.com/social-media/